Draxxin Kp 100 mg (DIN 02516683) — Marketed in Canada; Tulathromycin

Q: Is Tulathromycin registered outside Canada?

Yes — 88 matched registrations in 6 other markets.

Draxxin Kp 100 mg Solution is a Health Canada–registered veterinary drug (DIN 02516683) held by Zoetis Canada Inc, containing Tulathromycin. Health Canada lists its status as Marketed (status date 09 Sep 2021). Nexara Health has matched 88 registrations of Tulathromycin across 6 other regulated markets.

Health Canada registration

DIN	02516683
Brand name	Draxxin Kp
Active ingredient	Tulathromycin
Strength	100 mg
Dosage form	Solution
Route	Subcutaneous
Company	Zoetis Canada Inc
Status	Marketed — 09 Sep 2021
Class	Veterinary
ATC
AHFS
Regulator record	Health Canada DPD entry · Product monograph

Tulathromycin registered in other markets

88 registrations of the same molecule in 6 national registries outside Canada (first 42 shown, exact strength and form first). Each row is taken from the regulator's own published list; status is shown as the registry reports it.

Country	Product	Marketing authorisation holder	Strength	Form	Status	Registry
Denmark	Chanaxin	Chanelle Pharmaceuticals Manufacturing Limited	100 mg/ml	injektionsvæske, opløsning	Central	Laegemiddelstyrelsen
Denmark	Daxton	Cenavisa S.L.	100 mg/ml	injektionsvæske, opløsning	Decentral procedure	Laegemiddelstyrelsen
Denmark	Doraxx	Dopharma Research B.V.	25 mg/ml	injektionsvæske, opløsning	Decentral procedure	Laegemiddelstyrelsen
Denmark	Doraxx	Dopharma Research B.V.	100 mg/ml	injektionsvæske, opløsning	Decentral procedure	Laegemiddelstyrelsen
Denmark	Draxxin	Zoetis Belgium SA	100 mg/ml	injektionsvæske, opløsning	Central	Laegemiddelstyrelsen
Denmark	Draxxin	Zoetis Belgium SA	25 mg/ml	injektionsvæske, opløsning	Central	Laegemiddelstyrelsen
Denmark	Huvexxin	Huvepharma NV	25 mg/ml	injektionsvæske, opløsning	Decentral procedure	Laegemiddelstyrelsen
Denmark	Huvexxin	Huvepharma NV	100 mg/ml	injektionsvæske, opløsning	Decentral procedure	Laegemiddelstyrelsen
European Union (EMA)	Chanaxin	—			Authorised	EMA centrally authorised
European Union (EMA)	Draxxin	—			Authorised	EMA centrally authorised
European Union (EMA)	Increxxa	—			Authorised	EMA centrally authorised
European Union (EMA)	Lydaxx	—			Authorised	EMA centrally authorised
European Union (EMA)	Rexxolide	—			Authorised	EMA centrally authorised
European Union (EMA)	Tulatrixx	Emdoka BVBA			Application withdrawn	EMA centrally authorised
European Union (EMA)	Tulaven	—			Authorised	EMA centrally authorised
European Union (EMA)	Tulinovet	—			Authorised	EMA centrally authorised
Finland	Chanaxin	Chanelle Pharmaceuticals Manufacturing Limited	100 mg/ml	injektioneste, liuos	Myyntilupa myönnetty	Fimea Perusrekisteri
Finland	Draxxin	Zoetis Belgium	100 mg/ml	injektioneste, liuos	Myyntilupa myönnetty	Fimea Perusrekisteri
Finland	Draxxin	Zoetis Belgium	100 mg/ml	injektioneste, liuos	Myyntilupa myönnetty	Fimea Perusrekisteri
Finland	Draxxin	Zoetis Belgium	25 mg/ml	injektioneste, liuos	Myyntilupa myönnetty	Fimea Perusrekisteri
Finland	Increxxa	Elanco GmbH	100 mg/ml	injektioneste, liuos	Myyntilupa myönnetty	Fimea Perusrekisteri
Finland	Increxxa	Elanco GmbH	100 mg/ml	injektioneste, liuos	Myyntilupa myönnetty	Fimea Perusrekisteri
Finland	Increxxa	Elanco GmbH	25 mg/ml	injektioneste, liuos	Myyntilupa myönnetty	Fimea Perusrekisteri
Finland	Lydaxx	Vetoquinol S.A.	100 mg/ml	injektioneste, liuos	Myyntilupa myönnetty	Fimea Perusrekisteri
Malaysia	Increxxa 100 mg/ml solution for injection for cattle, pigs and sheep	Elanco Malaysia Sdn Bhd		Veterinary	PRODUCT APPROVED	NPRA
Malaysia	Macrosyn 100mg/ml solution for injection for cattle, pigs and sheep	F.e. Venture Sdn. Bhd.		Veterinary	PRODUCT APPROVED	NPRA
Malaysia	Tulaven 100mg/mL Solution For Injection	Ceva Animal Health Malaysia Sdn. Bhd.		Veterinary	PRODUCT APPROVED	NPRA
Malaysia	TULAVET AP 10% (w/v) SOLUTION FOR INJECTION	Sunzen Corporation Sdn Bhd		Veterinary	PRODUCT APPROVED	NPRA
Malaysia	TULLAVIS 100 mg/ml Solution For Injection	Yenher Agro-products Sdn. Bhd.		Veterinary	PRODUCT APPROVED	NPRA
Poland	Chanaxin	Chanelle Pharmaceuticals Manufacturing Ltd.	100 mg/ml	Roztwór do wstrzykiwań		URPL RPL
Poland	Daxton	Cenavisa S.L.	100 mg/ml	Roztwór do wstrzykiwań	Bezterminowe	URPL RPL
Poland	Doraxx	Dopharma Research B.V.	25 mg/ml	Roztwór do wstrzykiwań	Bezterminowe	URPL RPL
Poland	Doraxx	Dopharma Research B.V.	100 mg/ml	Roztwór do wstrzykiwań	Bezterminowe	URPL RPL
Poland	Draxxin	Zoetis Belgium SA	25 mg/ml	Roztwór do wstrzykiwań		URPL RPL
Poland	Forespix	Przedsiębiorstwo Wielobranżowe Vet-Agro Sp. z o.o.	100,00 mg/ml	Roztwór do wstrzykiwań	Bezterminowe	URPL RPL
Poland	Huvexxin	Huvepharma NV	100 mg/ml	Roztwór do wstrzykiwań	Bezterminowe	URPL RPL
Poland	Huvexxin	Huvepharma NV	25 mg/ml	Roztwór do wstrzykiwań	Bezterminowe	URPL RPL
United States	tulathromycin	Pharmacia & Upjohn Company LLC		Powder		FDA NDC
United States	tulathromycin	Jiangsu Willing Bio-Tech Co., Ltd.		Powder		FDA NDC
United States	Tulathromycin	Wisdom Pharmaceutical Co., Ltd.		Powder		FDA NDC
United States	Tulathromycin	Hisun Pharmaceutical (Nantong) Co., Ltd.		Powder		FDA NDC
United States	Tulathromycin	Amicogen(China) Biopharm Co., Ltd		Powder		FDA NDC

See every manufacturer of Tulathromycin worldwide →

Sourcing through Nexara Health

Nexara Health is a Health Canada–licensed wholesaler (DEL #3-002896) in Winnipeg. Because this DIN is marketed in Canada, supply normally comes through the Canadian channel; where the Canadian presentation is short or discontinued, the registrations above show which regulated markets hold an equivalent that can be imported under the Special Access Programme or for clinical comparator use. Request a quote or read how named-patient and foreign-pack supply works in Canada.

Frequently asked questions

Is Draxxin Kp (DIN 02516683) marketed in Canada?

Yes. Health Canada lists DIN 02516683 as Marketed as of 09 Sep 2021.

Who holds the Canadian licence for this product?

Zoetis Canada Inc is the company of record in the Health Canada Drug Product Database.

Is Tulathromycin registered outside Canada?

Yes — Nexara Health has matched 88 registrations in 6 other markets (see the table above).

Where does this data come from?

Health Canada Drug Product Database (DPD), DIN 02516683, status date 2021-09-09; national medicine registries: EMA centrally authorised, FDA NDC, Fimea Perusrekisteri, Laegemiddelstyrelsen, NPRA, URPL RPL. Nexara Health re-checks these sources weekly and shows the last verification date at the top of the page.

Source: Health Canada Drug Product Database (DPD), DIN 02516683, status date 2021-09-09; national medicine registries: EMA centrally authorised, FDA NDC, Fimea Perusrekisteri, Laegemiddelstyrelsen, NPRA, URPL RPL.

Zoetis Canada Inc — company profile Who else makes Tulathromycin All Canadian Tulathromycin products

Health Canada Drug Product Database (DPD), DIN 02516683, status date 2021-09-09; national medicine registries: EMA centrally authorised, FDA NDC, Fimea Perusrekisteri, Laegemiddelstyrelsen, NPRA, URPL RPL. Last reviewed 2026-09-16. Nexara Health is a licensed wholesaler and supplies licensed entities only; consumer orders are routed to a partner pharmacy.